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The translation product of the bovine herpesvirus-1 (BHV-1) gH gene was identified and characterized. Synthetic peptides 
were used to generate specific antisera and a glycoprotein of 108K was precipitated by one of the antisera. Cross- 
immunoprecipitations with monoclonal antibodies to BHV-1 glycoprotein gpl08 and the anti-gH peptide antiserum demon- 
strated that gpl08 is the translation product of the gH open reading frame. Glycoprotein gH synthesis and intracellular 
processing was analyzed in infected Madin-Darby bovine kidney cells using anti-gpl08 monoclenal antibodies. Glycoprotein 
gH is expressed as a beta-gamma protein and could be detected by radioimmunoprecipitation as early as 2 hr postinfection. 
Ootranslational N-glycosylation of gH is essential for the recognition by monoclonal antibodies, suggesting that N-linked 
glycans are involved in protein folding or that they are targets for most of monoclonal antibodies used in this study. 
© 1995 Academic Press, Inc. 
Bovine herpesvirus-1 (BHV-1), which belongs to the 
alphaherpesvirus subfamily, is an economically im- 
portant pathogen of cattle responsible for various dis- 
eases like infectious bovine rhinotracheitis (IBR), abor- 
tions, conjunctivitis, and infectious pustular vulvovaginitis 
(IPV) (6). Three BHV-1 glycoproteins have been exten- 
sively studied. Glycoprotein gl (herpes simplex virus-1 
(HSV-1) gB homologue) is a 130K disulfide-linked 74K/ 
55K heterodimer; gill (HSV-1 gC homologue) and gIV 
(HSV-1 gD homologue) are dimeric glycoproteins of 
180K/91K and 140K/71K, respectively (3, 11, 15). Four 
other BHV-1 glycoproteins have been identified through 
the production of monoclonal antibodies (MAbs); gll (2), 
gpl08, gp93, and gp42 (1), but their encoding genes re- 
mained to be identified. 
A gene encoding glycoprotein gH has been described 
in the genome of herpesviruses of all subfamilies includ- 
ing BHV-1 (14). BHV-1 glycoproteins gll and gpl08, which 
both have a 108K molecular weight, have recently been 
identified as identical proteins and their homology with 
HSV-1 gH was demonstrated by amino*terminal se- 
quencing (S. van Drunen Littel - van den Hurk, E. Bara- 
nowski, E. Thiry, D. Plainchamp, and L. A. Babiuk, submit- 
ted for publication). 
In this study, BHV-1 glycoprotein H was identified by 
the production of anti-gH peptide antisera and identity 
between gH and gpl08 was demonstrated by cross-im- 
munoprecipitations. Then, MAbs raised against gpl08 
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(1) were used to study glycoprotein gH synthesis and 
intracellular processing in infected Madin-Darby bovine 
kidney (MDBK) ceils. 
The amino acid sequence of the BHV-1 (Cooper strain) 
gH open reading frame was computer analyzed in order 
to predict the putative immunogenic regions. Based on 
the deduced hydrophobic profile, two peptides were se- 
lected and synthesized (7). Peptide 1, composed of 14 
amino acids (GGAGGRSREHRDAR) is situated near the 
amino terminus of the predicted polypeptide sequence 
of gH from positions 27 to 40. Peptide 2, consisting of 
13 amino acids (ADKRTEVEFSRGA), corresponds to resi- 
d.ues 747 to 769. Eight rabbits were immunized with pep- 
tides conjugated to porcine thyroglobulin using either 
glutaraldehyde (8) or carbodiimide (16) as the coupling 
agent and mixed with Freund's or water-soluble lipo- 
hexapeptide (Boehringer Mannheim) adjuvants. Sera 
collected after the third injection were analyzed by radio- 
immunoprecipitation using labeled BHV-1 (Cooper 
strain)-infected MDBK cell lysate as antigen. Radioimmu- 
noprecipitation and radiolabeling techniques used were 
described previously (1). Sera collected immediately be- 
fore the first immunization were used as controls (preim- 
munization sere). As shown in Fig. 1, SDS-PAGE analy- 
sis of immunoprecipitated proteins revealed that one se- 
rum precipitated a 108K protein from infected cells. This 
serum (1GF) was collected from a rabbit immunized with 
peptide 1 coupled by glutaraldehyde and mixed with 
Freund's adjuvant. No protein of the same molecular 
weight value was precipitated from radiolabeled mock- 
infected cells or by using preimmunization sera. 
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FIG. 1. Analysis of radioimmunoprecipitated proteins from bovine 
herpesvirus-1 infected cells (v) or mock-infected cells (c) by SDS-PAGE 
on a 7.5% acrylamide denaturing gel. Proteins were precipitated by 
anti-gH peptide rabbit sera 1GF (B), preimmunization rabbit sera (A), 
or anti-gpl08 MAb BH6 (C). 
No difference was observed between the electropho- 
retic mobility of the previously identified glycoprotein 
gpl08 precipitated by monoclonal antibody BH6 (1) and 
the 108K protein precipitated by the gH peptide antise- 
rum 1GF (Fig. 1). The identity between these two viral 
proteins was demonstrated by cross-immunoprecipita- 
tion. Radiolabeled BHV-1 infected cell lysate was incu- 
bated with anti-gpl08 monoclonal antibody BH6 coupled 
to protein A-Sepharose beads. Then, the supernatant of 
the precipitate was checked for the presence of gH by 
incubation with gH peptide antiserum 1GF. BHV-1 glyco- 
protein gH was not precipitated by gH peptide antiserum 
from the BH6-treated supernatant. However, this serum 
was still able to precipitate gH from the supernatant 
treated with rabbit anti-mouse immunoglobulins in the 
absence of the BH6 MAb (Fig. 2). Finally, as expected, 
gpl08 was immunoprecipitated by Mab BH6 from in- 
fected cell lysate pretreated with the preimmunization 
serum, but not with the anti-gH peptide antiserum 1GF 
(data not shown). These results demonstrate that glyco- 
protein gpl08 is the translation product of BHV-1 gH 
gene. 
The expression of glycoprotein gH was studied during 
each step of BHV-1 protein synthesis. BHV-1 alpha pro- 
teins were radiolabeled by cycloheximide and actinomy- 
cin D treatment as described by Ludwig and Letchworth 
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FIG. 3. Expression of BHV-1 gH in absence of DNA replication. Cells 
were infected and radiolabeled in the presence (+) or absence (-) 
of the DNA synthesis inhibitor phosphonoacetic acid (PAA). At 16 hr 
postinfection, proteins were precipitated from infected (v) or mock- 
infected cells (c) by MAb BH6 (A) or anti-gill MAb 1507 (B) and analyzed 
by SDS-PAGE on a 10% acrylamide denaturing gel. 
III (10). Glycoprotein gH was not immunoprecipited from 
infected cells, suggesting that this protein is not ex- 
pressed during alpha protein expression (data not 
shown). Beta proteins were identified by labeling in the 
presence of the DNA synthesis inhibitor phosphonoace- 
tic acid (PAA) (10). Immunoprecipitation of gH from in- 
fected cells was not influenced by the presence of PAA 
(Fig. 3). suggesting that glycoprotein gH synthesis is not 
dependent on DNA replication. The efficiency of PAA 
inhibition was checked by using MAb 1507 raised 
against glycoprotein gill (12), a gamma 2 (T2; true late) 
protein (Fig. 3). Pulse-chase experiments were per- 
formed to study the*course of glycoprotein gH synthesis 
during BHV-1 replication in MDBK cells. Proteins were 
radiolabeled at hourly intervals from 0to 8 hr postinocula- 
tion. Cells were first incubated in methionine-free mini- 
mum essential medium (MEM) for 30 rain before 1 hr 
labeling with 100 #Ci per ml of Tran 35S label (ION Flow) 
and then harvested after 30 min of incubation with unla- 
beled methionine. As shown in Fig. 4, glyprotein gH was 
immunoprecipitated as early as 2 hr postinculation and 
was still detected 8 hr postinoculation. Temporal appear- 
ance of glycoprotein gH in acetone fixed MDBK cells 
was investigated by indirect immunofluorescence where 
fluorescence was observed in the cytoplasm and in the 




FiG. 2. Analysis of radioimmunoprecipitated proteins from BHV-1- 
infected cells by SDS-PAGE on a 7.5% acrylamide denaturing gel. 
Proteins were precipitated by rabbit anti-mouse immunoglobulins 
(lanes A and B) or MAb BH6 (lanes C and D) followed by either preim- 
munization rabbit sera (lanes A and C) or anti-gH peptide rabbit sera 
1GF (lanes B and D). 
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FIG. 4. Temporal appearance of BHV-1 gH at 0, 1, 2, 3, 4, 5, 6, 7, and 
8 hr (lanes O to 8, respectively) after infection. Proteins radiolabeled at 
hourIy intervals were precipitated by MAb BH6 and analyzed by SDS- 
PAGE on a 10% acrylamide denaturing gel. Labeled mock-infected 
cells (c) were used as control. 
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RG. 5. Processing of BHV-1 glycoprotein H. At 16 hr postinfection, proteins were precipitated by MAb BH10 from infected (v) or mock-infected 
cells (c) radiolabeled in the presence (+) or absence (-) of tunieamycin (A) or monensin (B). Precipitates digested by Endo F (F), Endo H (H), or 
without enzyme (-) were precipitated from infected cells by MAb BH6 (C). Precipitates~were analyzed by SDS-PAGE on a 7.5% acrylamide denaturing 
gels. Molecular weight values were calculated from at least two different autoradiographs. 
postinoculation (data not shown). No fluorescence was 
observed in uninfected cell monolayers. 
Like BHV-1 glycoproteins gl and glV (4, 10), gH was 
synthesized during beta protein expression and could be 
detected by radioimmunoprecipitation as early as 2 hr 
after infection. Synthesis of glycoprotein gll was pre- 
viously identified at 2 hr postinfection (4), which is in 
agreement with the present observations. Pulse-chase 
experiments revealed that gH translation was still de- 
tected 8 hr after viral infection. Glyceprotein gill, which 
is classified as a T2 protein, was also identified during 
the same period of time (4, 10). Since gH expression did 
not decline significantly during viral DNA replication, this 
glycoprotein could be classified as a beta-gamma-regu- 
lated protein. 
BHV-1 glycoprotein gH sequence analYSiS indicated 
the presence of six potential N-linked glycosylation sites 
(14). Analysis of BHV-1 glycoprotein glI(GVP-7) pro- 
cessing in Georgia bovine kidney cells revealed that gll 
is processed by N-glycosylation from an Endo H-sensi- 
tive precursor of 100K to an Endo H partially resistant 
form of 108K, containing complex and high-mannose type 
eligosaccharides (3, 4). Availability of a panel of MAbs 
raised against gpl08 (1) allowed further investigation of 
the processing of BHV-1 gH. 
Protein radiolabeling in the presence of glycosylation 
inhibitors was described by van Drunen Littel-van den 
Hurk and Babiuk (3). When BHV-l-infected cells were 
labeled in the presence of tunicamycin, 18 of 20 MAbs 
raised against gH (BH6, BH8, BH10, BH14, BH18, BH19, 
BH20, BH23, BH25, BH27, BH48, BH55, BH59, BH60, 
BH61, BH62, BH64, BH67, BH68, and BH69) were unable 
to precipitate this glycoprotein and the renaming 2 MAbs 
(BH10 and BH67) precipitated a smaller protein with a 
molecular weight of 99-100 K (Fig. 5). In contrast, the 
conformation of gH was not altered in the presence of 
monensin, all IVlAbs tested were still able to precipitate 
this glycoprotein (Fig. 5). These results suggest that the 
presence of N-linked precursors on gH is crucial for epi- 
tope conformation and recognition by most of the MAbs 
used, although processing in the Golgi apparatus is dis- 
pensable. 
The sensitivity of glycoprotein gH to digestion with 
endoglycosidase F/N-glycosidase F (Endo F; Boehringer 
Mannheim) and endoglycosidase H (Endo H; Boehringer 
Mannheim) was tested. Digestions were performed fol- 
lowing the recommendations of the manufacturer. Radio- 
labeled gH immunoprecipitated by MAb BH6 was resis- 
tant to Endo H treatment but a molecular weight shift 
from 108K to 91K was observed after Endo F digestion 
(Fig. 5). A difference of 8-9K was observed between 
the unglycosylated precursor immunoprecipitated after 
tunicamycin treatment (99-100K) and the gH Endo F di- 
gest (91K). This difference in the apparent molecular 
weights may be due to either a proteolytic degradation 
of the Endo F digest or a post-translational proteolytic 
cleavage of the N-glycosylated precursor which does not 
occur on the unglycosylated tunicamycin-treated form. A 
study on intracellular processing of measles virus fusion 
protein (F) also showed that addition of N-linked oligo- 
saccharides is an essential step for proteolytic cleavage 
of the F protein (18). Presence of the N-linked precursor 
is also important for the hypothetical proteolytic pro- 
cessing of gH. Resistance to Endo H treatment indicates 
that high-mannose glycans are completely processed to 
complex or hybrid forms, in contrast with that seen in 
the presence of high-mannose sugars on gll (4). Never- 
theless, this difference is probably dependent on the cell 
line in which the virus was grown. 
Complex formation between glycoproteins gH and gL 
have been described in several alphaherpesviruses (5, 
9, 13). This association is essential for gH transport, gly- 
cosylation, and epitope formation (9, 13, 17). No associa- 
tion between BHV-1 gH and any other viral proteins could 
be observed in radioimmunoprecipitation assays using 
anti-gH MAbs (1) or anti-gH peptide antiserum 1GF (data 
not shown). There may be several reasons for this obser- 
vation= (i) there is no complex formation between BHV-1 
glycoproteins gH and gL, (ii) the gH:gL complex formation 
in cells is only transient, (iii) the complex formation inhib- 
:its its recognition by the anti-gH MAbs and the anti-gH 
peptide antiserum 1GF, or (iv) the gH,gL complex was 
disrupted under the experimental conditions used. In 
several experiments, a 108K protein was coprecipitated 
when BHV-1 glycoprotein gp42 was immunoprecipitated 
from infected cell lysates using anti-gp42 MAb BH44 
654 SHORT COMMUNICATIONS 
(data not shown). This protein has the same molecular 
weight as gH, suggesting that gp42 could be associated 
with gH during processing in infected cells. However, 
this coprecipit ion was only sporadical ly observed and 
the identity of this 108K eoprecipitated protein and gH 
remains to be demonstrated. Expression of BHV-1 gH 
gene in transfected cells could al low one to investigate 
the relationship between gH and gL processing. 
In conclusion, BHV-1 glycoprotein gp108 is the transla- 
tion product of the BHV-1 gH gene. Since gH is present 
very early after infection and is still synthesized during 
late expression, this glycoprotein might be an imporLant 
vaccine antigen, Glycosylation is essential for its recogni- 
tion by monoclonal antibodies, suggesting that N-linked 
glycans are involved in protein folding or that they are 
targets for most of the monoclonal antibodies used. Car- 
bohydrate moieties are thus directly or indirectly involved 
in the antigenicity of BHV-1 gH. 
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